Clinical Trial Update: Trial of Belimumab in Early Lupus [Phase 4]

View source ↗

Summary

Phase 4 trial updating on belimumab in early systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Northwell Health | Conditions: Lupus Erythematosus, Systemic, Lupus Erythematosus | Phase 4 | Status: RECRUITING